Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Gartner, Magic Quadrant for Custom Software Development Services, By Jaideep Thyagarajan, Ryan McKinney, Nathan Davie, 7 October 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Hexaware.
Flyer
Clinical studies lose time after protocol approval because the same information is repeatedly interpreted and re-entered across EDC, CTMS, IWRS, data management, monitoring, and documentation workflows. This creates avoidable delay, inconsistent definitions, and traceability gaps.
The industry is already moving from document-centric protocols toward structured study definitions. TransCelerate’s Digital Data Flow initiative advances protocol digitalization, CDISC USDM provides a standard model for exchanging study-definition information, and ICH M11 establishes a harmonized protocol structure. The opportunity is not only to prepare for that shift, but to improve study start-up now.
Hexaware’s Digital Data Flow Accelerator converts protocol content into a governed CDISC USDM 4.0 study definition. After validation and approval, the record can be published through an SDR Hub and made available to existing systems and document workflows through APIs or governed exports. This supports downstream activities such as EDC and CTMS setup, IWRS workflows, data management plans, central monitoring plans, and other study assets without forcing a wholesale platform replacement.
Traceability is central to the approach. Extracted study elements and review answers link to the supporting protocol page or section, allowing teams to verify evidence before approval. Automation accelerates extraction and drafting, while validation, governance, and human review keep the approved record controlled.
Inside this flyer:
Learn how Hexaware Digital Data Flow Accelerator enable clinical development while improving quality, compliance, and operational efficiency.